Indicaciones e interpretación de la resonancia magnética cardíaca

  1. García Campos, A. 1
  2. Pérez Domínguez, M. 1
  3. Díaz Fernández, B. 1
  4. González Juanetey, J.R. 1
  1. 1 Servicio de Cardiología, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, España, CIBERCV
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2021

Issue Title: Enfermedades cardiovasculares (VIII)

Series: 13

Issue: 42

Pages: 2490-2493

Type: Article

DOI: 10.1016/J.MED.2021.09.026 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

Cardiac magnetic resonance is a fundamental technique in the study of cardiomyopathies. Its main value lies in the great precision and reproducibility of ventricular volumes, ejection fraction, parietal thickness, and myocardial mass measurements as well as its ability to characterize tissue, which allows for refining the etiological diagnosis. The group that most benefits from a cardiac magnetic resonance study is patients suspected of having cardiomyopathy, whose diagnosis cannot be established via echocardiogram due to technique limitations (poor window). This technique would be indicated in the etiological study of dilated cardiomyopathies and in hypertrophic phenotypes. Another strength of cardiac magnetic resonance is the demonstrated prognostic value of its findings in this group of patients.

Bibliographic References

  • Doherty JU, Kort S, Mehran R, Kort S, Mehran R, Schoenhagen P. Appropriate use criteria for multimodality imaging in the assessment of cardiac structure and function in nonvalvular heart disease: A report of the American College of Cardiology appropriate use criteria. J Am Soc Echocardiogr. 2019;32(5):553-79.
  • Donal E, Delgado V, Bucciarelli-Ducci C, Galli E, Haugaa KH, Charron P. Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: An expert consensus document from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2019;20(10):1075-93.
  • Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(39): 2733-79.
  • Halliday BP, Gulati A, Ali A, Guha K, Newsome S, Arzanauskaite M. Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation. 2017;135(22):2106-15.
  • Indik JH, Gimbel JR, Abe H, Alkmim-Teixeira R, Birgersdotter-Green U, Clarke GD. 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Hear Rhythm. 2017;14(7):e97-e153.
  • Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER, et al. Normal values for cardiovascular magnetic resonance in adults and children. J Cardiovasc Magn Reson. 2015;17(1):1-33.
  • Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non ischaemic cardiomyopathies. Eur Heart J. 2005;26(15):1461-74.
  • Manning WJ, Pennell DJ. Cardiovascular magnetic resonance. 2ª ed. Philadelphia: Elsevier; 2010.
  • Patel AR, Kramer CM. Role of cardiac magnetic resonance in the diagnosis and prognosis of nonischemic cardiomyopathy. JACC Cardiovasc Imaging. 2017;10(10):1180-93.
  • Petersen SE, Aung N, Sanghvi MM, Zemrak F, Fung K, Paiva JM. Reference ranges for cardiac structure and function using cardiovascular magnetic resonance (CMR) in Caucasians from the UK Biobank population cohort. J Cardiovasc Magn Reson. 2017;19(1):1-19.
  • Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution. Eur Heart J. 2016;37: 2129-200.
  • Van Der Ven JPG, Sadighy Z, Valsangiacomo Buechel ER, Sarikouch S, Robbers-Visser D, Kellenberger CJ. Multicentre reference values for cardiac magnetic resonance imaging derived ventricular size and function for children aged 0-18 years. Eur Heart J Cardiovasc Imaging. 2020;21(1):102-13.
Data source: Dialnet